You are here

  • Home
  • Archive
  • Volume 68, Issue Suppl 3
  • P101 Does Ivacaftor improve objective measurements of health in patients with the G551D cystic fibrosis transmembrane conductance regulator (CFTR) protein mutation? The experience of a UK cystic fibrosis centre

Alerts

Article menu

Download PDFPDF

Bronchiectasis
P101 Does Ivacaftor improve objective measurements of health in patients with the G551D cystic fibrosis transmembrane conductance regulator (CFTR) protein mutation? The experience of a UK cystic fibrosis centre
Free
You need to be signed in to access email alerts. If you have an account log in with your user name and password. If you don't have an account you can just enter your email address in the email box below.
Sign In to Email Alerts with your Email Address